Company Filing History:
Years Active: 2021
Title: Yanxin Zheng: Innovator in Pharmaceutical Development
Introduction
Yanxin Zheng is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for heart failure. His innovative work has led to the creation of a unique composite that combines various therapeutic agents.
Latest Patents
Yanxin Zheng holds a patent for an "Angiotensin II receptor antagonist metabolite and NEP inhibitor composite and preparation method thereof." This invention provides a supramolecular composite that includes an angiotensin II receptor (AT1) blocking compound, a neutral endopeptidase inhibitor (NEPi), and a pharmaceutically acceptable cation. The patent outlines a method for preparing this composite and its application in creating pharmaceutical products aimed at treating heart failure. He has 1 patent to his name.
Career Highlights
Yanxin Zheng is currently employed at Shenzhen Salubris Pharmaceuticals Co. Ltd. His role at the company allows him to apply his expertise in pharmaceutical innovation and contribute to the development of new treatments. His work is characterized by a commitment to improving patient outcomes through advanced therapeutic solutions.
Collaborations
Yanxin Zheng collaborates with notable colleagues, including Jie Gandalf Yan and Wenjie Xu. These partnerships enhance the research and development efforts at Shenzhen Salubris Pharmaceuticals Co. Ltd., fostering an environment of innovation and teamwork.
Conclusion
Yanxin Zheng's contributions to pharmaceutical development, particularly in heart failure treatment, highlight his role as an influential inventor in the industry. His innovative patent and collaborative efforts continue to drive advancements in healthcare solutions.